Guillain-Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506.
Autor(es): Moon Joon-Shik; Souayah Nizar
Resumo: Guillain-Barré syndrome (GBS) has been rarely reported after liver transplantation and generally has good outcome. We report a liver transplant patient on FK506 (tacrolimus) who developed GBS 6 months after liver transplantation. There was no evidence of liver rejection or active infection. Despite treatment with intravenous immunoglobulin, the patient expired. GBS occurred despite downregulation of T cells by FK506, suggesting that humoral dysfunction might be the predominant mechanism of GBS in this report.
Imprenta: Liver Transplantation, v. 12, n. 10, p. 1537-1539, 2006
Identificador do objeto digital: 10.1002/lt.20864
Descritores: Guillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Vaccine ; Guillain-Barre Syndrome - Public health
Data de publicação: 2006
